News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Rahul Banerjee: Updates in chronic lymphocytic leukemia at BTFHem25
Rahul Banerjee/X
Jan 21, 2025, 06:46

Rahul Banerjee: Updates in chronic lymphocytic leukemia at BTFHem25

Rahul Banerjee, Assistant Professor at Fred Hutchinson Cancer Center, posted the following on X:

“Good to see Christina Poh (fellow Fred Hutch faculty) here on the podium to teach us about CLL here at Binaytara Foundation’s BTFHem25 in Portland!

Jealous that you guys have venetoclax as an FDA-approved drug while we don’t yet in myeloma.”

Rahul Banerjee

academic conferences Binaytara Foundation BTFHem25 cancer Cancer research cancer treatment advancements chronic lymphocytic leukemia CLL FDA-approved therapies Fred Hutch leukemia updates Myeloma OncoDaily Oncology Rahul Banerjee venetoclax
Special Coverage
Blog
Jan 21, 2025, 06:46
Rahul Banerjee: Updates in chronic lymphocytic leukemia at BTFHem25
Blog
Jan 21, 2025, 06:43
SPCC: Outlook for the HR+/HER2- MBC treatment landscape in 2025 and beyond
Blog
Jan 21, 2025, 06:35
Leading experts reviewing practice-changing publications in HCC and stage III melanoma - ESMO
Blog
Jan 21, 2025, 06:28
ASCO Thanks Drs. Bertagnolli, Rathmell for Their Service Leading NIH, NCI
Career
Jan 21, 2025, 06:24
Justin Taylor was elected to the ASCI - Sylvester Comprehensive Cancer Center
Insight
Jan 21, 2025, 06:22
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy
Insight
Jan 21, 2025, 06:17
Fabio Moraes: Global linear accelerator requirements and personalised country recommendations
Blog
Jan 21, 2025, 06:15
Petros Grivas: Excited for our 12th Immune-related Adverse Events panel CME series
Blog
Jan 21, 2025, 05:44
Aruni Ghose: Collaboration with Dr. Swarupa Mitra on innovative cancer care
Blog
Jan 21, 2025, 05:12
Intratumoral, pembrolizumab and mRNA-2752 for high-risk Ductal Carcinoma In Situ
Blog
Jan 21, 2025, 05:10
Mark Lawler: The severe cancer workforce crisis - a ticking time bomb that must be diffused to avert a cancer crisis
Blog
Jan 21, 2025, 04:58
The 2025 American Cancer Society Cancer Statistics report